Error reduction and risk management in cytopathology

Seminars in Diagnostic Pathology

Volumn 24, Issue 2, 2007, Pages 77-88

  Frable, William J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cervicovaginal cytology; Fine needle aspiration biopsy; Medical malpractice; Risk management

Indexed keywords

ARTICLE; BILLING AND CLAIMS; BLOOD SMEAR; BREAST BIOPSY; CANCER DIAGNOSIS; CONSUMER; CYTOPATHOLOGY; CYTOTECHNOLOGIST; DIAGNOSTIC ERROR; HUMAN; INSURANCE; LABORATORY DIAGNOSIS; LAW SUIT; MALPRACTICE; NEGLIGENCE; PATHOLOGIST; PATIENT EDUCATION; PEER REVIEW; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; RISK MANAGEMENT; RISK REDUCTION; SKIN DEFECT; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DIAGNOSIS; WART VIRUS;

AGED; DEFENSIVE MEDICINE; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MEDICAL ERRORS; MIDDLE AGED; RISK MANAGEMENT; UTERINE CERVICAL DISEASES; VAGINAL SMEARS;

EID: 34250380644     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2007.03.006     Document Type: Article

References (46)

1. In: Kohn L.T., Corrigan J.M., and Donaldson M.S. (Eds). To Err is Human. Building a Safer Health System (2000), National Academy Press, Washington DC
2. Keepmews D., and Mitchell P.H. Health systems' accountability for patient safety. Online J Issues Nurs 8 (2003) 2
3. Clinton H.R., and Obama B.S. A bill to amend the Public Health Service Act to promote a culture of safety within the health care system through establishment of a National Medical Error Disclosure and Compensation Program (2005) Press Release, Barack Obama, September 28
4. Koss L.G., and Melamed M.R. Koss' Diagnostic Cytopathology and Its Histopathologic Bases. (ed 5) (2006), Lippincott Williams & Wilkins, Philadelphia, PA 8-9
5. Priest P., Sadler L., Peters J., et al. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading. BJOG 114 (2007) 398-407
6. Troxel D.B., and Sabella J.D. Problem areas in pathology practice. Uncovered by a review of malpractice claims. Am J Surg Pathol 18 (1994) 821-831
7. Troxel D.B. Error in surgical pathology. Am J Surg Pathol 28 (2004) 1092-1095
8. Troxel D.B. Medicolegal aspects of error in pathology. Arch Pathol Lab Med 130 (2006) 617-619
9. Troxel D.B. Diagnostic pitfalls in surgical pathology: uncovered by a review of malpractice claims. Part II. Breast fine needle aspirations. Int J Surg Pathol 8 (2000) 229-231
10. Troxel D.B. Diagnostic pitfalls in surgical pathology: discovered by a review of malpractice claims. Part III. Breast biopsies. Int J Surg Pathol 8 (2000) 335-337
11. Troxel D.B. Diagnostic pitfalls in surgical pathology: discovered by a review of malpractice claims. Part VII. Random errors. Int J Surg Pathol 9 (2001) 305-308
12. Troxel D.B. Pitfalls in the diagnosis of malignant melanoma; findings of a risk management panel study. Am J Surg Pathol 27 (2003) 1278-1283
13. Troxel D.B. Diagnostic pitfalls in surgical pathology: discovery by a review of malpractice claims. Int J Surg Pathol 9 (2001) 133-136
14. Voelker R. Milwaukee deaths reignite critical issues in cervical cancer screening. J Am Med Assoc 273 (1995) 1559-1560
15. The Doctors Company, unpublished data
16. Shoop S.A. Cervical cancer screening risk management perspectives (2006), Corporate Laser, Great Falls, VA PIAA Claims Workshop, October 19, 2006.
17. Wied G.L. Quality control mechanism for cytology programs. Acta Cytol 9 (1965) 407-412
18. Inhorn S.L. Governmental legislation affecting cytology laboratories. Acta Cytol 20 (1976) 197-202
19. New pap tests suggested for air force dependents. US Medicine 1 (1978) August
20. Bogdanich W. The Pap test misses much cervical cancer through lab's efforts. The Wall Street Journal 1 (1987) Nov 2
21. Bogdanich W. Physician's carelessness with Pap tests is cited in procedure's high failure rate. The Wall Street Journal 17 (1987) Dec 29
22. Frable W.J. Litigation in gynecologic cytology. Pathol Case Rev 10 (2005) 106-114
23. Austin R.M. Results of blinded rescreening of Papanicolaou smears versus biased retrospective review. Arch Pathol Lab Med 121 (1997) 311-314
24. Renshaw A.A., Young M.L., and Holladay E.B. Blinded review of Papanicolaou smears in the context of litigation. Cancer 102 (2004) 136-141
25. Jamal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
26. Frable W.J., Austin R.M., Greening S.E., et al., International Academy of Cytology Task Force summary. Medicolegal affairs. Diagnostic cytology towards the 21st century: an international expert conference and tutorial. Acta Cytol 42 (1998) 76-119 discussion 120-132
27. Rosenthal DL, Marzella RJ: Cytoteleconference. American Society of Cytopathology, Philadelphia, 1996-97
28. Austin R.M. In search of a "reasonable person standard" for gynecologic cytologists. Diagn Cytopathol 11 (1994) 216-218
29. Fitzgibbons P.L., Austin R.M., and Surgical Pathology Committee and Cytopathology Committee of the College of American Pathologists. Expert review of histologic slides and Papanicolaou tests in the context of litigation or potential litigation. Arch Pathol Lab Med 124 (2000) 1717-1719
30. Web site, American Society of Cytopathology. Available at. http://www.cytopathology.org/.
31. Raab S.S., Andrew-Jaja C., Condel J.L., et al. Improving Papanicolaou test quality and reducing medical errors by using Toyota production system methods. Am J Obstet Gynecol 194 (2006) 57-64
32. Vrbin C.M., Grzybicki D.M., Zaleski M.S., et al. Variability in cytologic-histologic correlation practices and implications for patient safety. Arch Pathol Lab Med 129 (2005) 893-898
33. Solomon D., and Nayar R. The Bethesda System for Reporting Cervical Cytology. 2nd Edit. (2004), Springer-Verlag, New York, NY
34. Davey E., Barratt A., Irwig L., et al. Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 367 (2006) 122-132
35. Willis B.H., Barton P., Pearmain P., et al. Cervical screening programmes: can automatioin help?. Evidence from systematic reviews, an economic analysis and a simulation modeling exercise applied to the UK. Health Technol Assess 9 (2005) 1-207
36. Wilbur D.C., Parker E.M., and Foti J.A. Location-guided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial. Am J Clin Pathol 118 (2002) 399-407
37. Wilbur D.C., and Stoler M.H. Testing for human papillomavirus: basic pathobiology of infection, methodologies, and implications for clinical use. Yale J Biol Med 64 (1991) 113-125
38. Stoler M.H. Testing for human papillomavirus: data driven implications for cervical neoplasia management. Clin Lab Med 23 (2003) 569-583
39. Stoler M.H. HPV testing in cervical cytology practice: it's all about choice. Acta Cytol 49 (2005) 117-119
40. HMSO. Report of the working party on internal quality control for cervical cytopathology laboratories (1995) Ediburgh, The Scotish Office
41. Dudding N., Hewer E.M., Lancucki L., et al. Rapid screening: a comparative study. Cytopathology 12 (2001) 235-248
42. Yobs A.R., Plott A.E., Hicklin M.D., et al. Retrospective evaluation of gynecologic cytodiagnosis. II. Intralaboratory reproducibility as shown in rescreening large consecutive samples of reported cases. Acta Cytol 31 (1987) 900-910
43. Davey D.D. Papanicolaou smear 5-year retrospective review: what is required by the Clinical Laboratory Improvement Amendments of 1988?. Arch Pathol Lab Med 121 (1997) 296-298
44. Davey D.D. Amended reports: when, if ever?. Diagn Cytopathol 17 (1997) 399-400
45. Stastny J.F., Geisinger K.R., Michael C.W., et al. Another quality assurance issue-uamended reports: what do we really know about them?. Diagn Cytopathol 18 (1998) 67-70
46. Epstein J.I. Pathologists and the judicial process: how to avoid it. Am J Surg Pathol 25 (2001) 527-537